Table 4.
Predictive accuracy of HOXA9 and NID2 on head and neck cancer saliva samples. (n=51)
| Predictor | Sensitivity % |
Specificity % |
AUC | Methylation Cutoff value |
|---|---|---|---|---|
| Oral and oropharyngeal cancer (n=51) | ||||
| HOXA9 | 63 | 53 | 0.65 | 13.11 |
| NID2 | 72 | 21 | 0.57 | 11.48 |
| Oral cancer (n=35) | ||||
| HOXA9 | 75 | 53 | 0.75 | 13.11 |
| NID2 | 87 | 21 | 0.73 | 11.48 |
| HOXA9 and | 50 | 90 | 0.75 | * |
| NID2 | ||||
Classified positive (+) if predicted probability for positive outcome (tumor) >= than 0.5